Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIR
1726
DELISTED
CIRCOR International, Inc
CIR
| $2.32M | ﹤0.01% |
50,197
+2,957
| +6% | +$122K |
|
|
WAIR
1727
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $2.32M | ﹤0.01% |
210,454
+5,965
| +3% | +$65.6K |
|
1728
Sturm, Ruger & Co
RGR
$616M
| $2.31M | ﹤0.01% |
49,016
+2,894
| +6% | +$131K |
|
1729
SiteOne Landscape Supply
SITE
$4.42B
| $2.3M | ﹤0.01% |
25,386
+3,619
| +17% | +$307K |
|
1730
Morningstar
MORN
$7.46B
| $2.3M | ﹤0.01% |
15,195
+237
| +2% | +$36.4K |
|
1731
Ambev
ABEV
$47.1B
| $2.3M | ﹤0.01% |
493,556
-3,946,103
| -89% | -$17.5M |
|
1732
Virtus Investment Partners
VRTS
$1.13B
| $2.3M | ﹤0.01% |
18,886
+2,423
| +15% | +$270K |
|
1733
Sinclair Inc
SBGI
$1B
| $2.3M | ﹤0.01% |
68,898
+8,259
| +14% | +$308K |
|
|
WW
1734
DELISTED
WW International
WW
| $2.29M | ﹤0.01% |
+59,982
| New | +$2.28M |
|
1735
Triumph Financial Inc
TFIN
$1.83B
| $2.29M | ﹤0.01% |
60,268
+3,089
| +5% | +$107K |
|
1736
Delek US
DK
$4.06B
| $2.29M | ﹤0.01% |
68,313
+6,379
| +10% | +$230K |
|
|
IPHI
1737
DELISTED
INPHI CORPORATION
IPHI
| $2.28M | ﹤0.01% |
30,826
+6,303
| +26% | +$433K |
|
1738
Tandem Diabetes Care
TNDM
$1.38B
| $2.28M | ﹤0.01% |
38,199
+5,279
| +16% | +$326K |
|
1739
DNOW Inc
DNOW
$2.6B
| $2.27M | ﹤0.01% |
202,409
+17,401
| +9% | +$194K |
|
1740
Vanda Pharmaceuticals
VNDA
$315M
| $2.27M | ﹤0.01% |
138,292
+10,422
| +8% | +$158K |
|
|
KRA
1741
DELISTED
Kraton Corporation
KRA
| $2.27M | ﹤0.01% |
89,605
+4,899
| +6% | +$119K |
|
1742
Atkore
ATKR
$3.16B
| $2.26M | ﹤0.01% |
55,864
+45,894
| +460% | +$1.7M |
|
1743
Kratos Defense & Security Solutions
KTOS
$9.73B
| $2.26M | ﹤0.01% |
125,488
+3,594
| +3% | +$66.7K |
|
|
MRTX
1744
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.26M | ﹤0.01% |
17,530
+1,067
| +6% | +$103K |
|
|
PGTI
1745
DELISTED
PGT, Inc.
PGTI
| $2.26M | ﹤0.01% |
151,395
+8,840
| +6% | +$141K |
|
1746
Guardant Health
GH
$21.3B
| $2.25M | ﹤0.01% |
28,861
+5,098
| +21% | +$367K |
|
1747
InterDigital
IDCC
$7.98B
| $2.25M | ﹤0.01% |
41,364
+4,912
| +13% | +$271K |
|
|
NXGN
1748
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.25M | ﹤0.01% |
140,182
+9,178
| +7% | +$152K |
|
1749
RadNet
RDNT
$5.25B
| $2.25M | ﹤0.01% |
110,759
+98,311
| +790% | +$1.69M |
|
1750
Universal Insurance Holdings
UVE
$1.23B
| $2.23M | ﹤0.01% |
79,710
+4,793
| +6% | +$139K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.